Robert E. Gagnon

Companies

• Kitov PharmaBoard member Mar 18, 2026 to now¹
• Opus Genetics, Inc.Chief financial officer Sep 11, 2025 to now²
• Harvard BioscienceBoard member Jul 18, 2025 to now³
• Bone Biologics CorpBoard member Jan 10, 2024 to now⁴
• Verastem OncologyBoard member Dec 15, 2022 to now⁵
• Verastem OncologyChief financial officer Aug 30, 2018 to Sep 21, 2022⁶
• Harvard BioscienceChief financial officer Nov 18, 2013 to Aug 30, 2018⁷
• Clean HarborsChief financial officer Aug 22, 2012 to Sep 13, 2012⁸
• BiogenChief Acct Officer VP & Contol Nov 10, 2010 to Mar 1, 2012⁹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KPKitov Pharma PPBT3,062,500 shares¹⁰$3.8M at $1.23Mar 18, 2026
• OGOpus Genetics, Inc. IRD556,375 shares¹¹$2.3M at $4.05Sep 3, 2026
• Verastem Oncology VSTM41,678 shares¹²$383.2K at $9.20Dec 16, 2025
• Harvard Bioscience HBIO27,556 shares¹³$229.0K at $8.31Jun 9, 2026
• BBBone Biologics Corp BBLG0 shares¹⁴Jan 10, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 3, 2026Sold 28,000 shares at $4.54 of Opus Genetics, Inc.¹¹
• Jul 23, 2026Sold 7,783 shares at $2.95 of Opus Genetics, Inc.¹⁵
• Jun 9, 2026Granted 16,556 shares of Harvard Bioscience¹³
• Apr 23, 2026Sold 7,842 shares at $5.18 of Opus Genetics, Inc.¹⁶
• Jan 22, 2026Granted 400,000 shares of Opus Genetics, Inc.¹⁷
• Dec 16, 2025Sold 283 shares at $9.14 of Verastem Oncology¹²
• Sep 16, 2025Sold 281 shares at $9.99 of Verastem Oncology¹⁸
• Sep 10, 2025Granted 200,000 shares of Opus Genetics, Inc.¹⁹
• Jul 16, 2025Granted 110,000 shares of Harvard Bioscience²⁰
• Jun 16, 2025Sold 284 shares at $5.65 of Verastem Oncology²¹
• May 22, 2025Granted 8,333 shares of Verastem Oncology²²
• Mar 17, 2025Sold 284 shares at $6.95 of Verastem Oncology²³
• Dec 19, 2024Sold 130 shares at $4.37 of Verastem Oncology²⁴
• Dec 16, 2024Sold 285 shares at $4.54 of Verastem Oncology²⁴
• Sep 19, 2024Sold 131 shares at $2.79 of Verastem Oncology²⁵
• Sep 16, 2024Sold 287 shares at $2.80 of Verastem Oncology²⁶
• Jun 20, 2024Sold 131 shares at $3.21 of Verastem Oncology²⁷
• Jun 18, 2024Granted 8,333 shares of Verastem Oncology²⁷
• Jun 17, 2024Sold 283 shares at $3.49 of Verastem Oncology²⁷
• Mar 19, 2024Sold 130 shares at $10.38 of Verastem Oncology²⁸
• Mar 18, 2024Sold 283 shares at $10.71 of Verastem Oncology²⁸
• Feb 6, 2024Sold 9,204 shares at $13.70 of Verastem Oncology²⁹
• Jan 12, 2024Sold 9,204 shares at $10.95 of Verastem Oncology³⁰
• Dec 19, 2023Sold 130 shares at $7.73 of Verastem Oncology³¹
• Dec 18, 2023Sold 284 shares at $7.64 of Verastem Oncology³¹